1989
DOI: 10.1111/j.1349-7006.1989.tb01648.x
|View full text |Cite
|
Sign up to set email alerts
|

In vivo Antitumor Mechanism of Natural Human Tumor Necrosis Factor Involving a T Cell‐mediated Immunological Route

Abstract: We have investigated the in vivo antitumor mechanism of natural human tumor necrosis factor (n‐TNF) isolated from a culture of human leukemic B cell line (BALL‐1), especially its action as an immunomodulator, and found that the in vivo antitumor effect of n‐TNF on Meth A sarcoma implanted in BALB/c mice pretreated with monoclonal antibody against T cell‐specific surface antigen (Thy‐1) was significantly diminished. Furthermore, when BALB/c mice were treated with T cell subset‐specific monoclonal antibodies, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

1990
1990
2009
2009

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 18 publications
0
5
0
Order By: Relevance
“…In effect, by localizing the delivery of TNF to solid tumors, Lienard and Lejuene harnessed the biology of TNF to induce at least one of the possible mechanisms by which the cytokine induces an anti-tumor response. For example, TNF has been shown to cause apoptosis directly in various tumor cell types Helson et al, 1975], to activate and drive immune-based anti-tumor responses [Asami et al, 1989], and to induce vascular leak in tumor blood vessels [Nawroth and Stern, 1986;Brett et al, 1989], leading to a destruction of the interstitial fluid pressure (IFP) gradient in solid tumors [Kristensen et al, 1996;Nedrebo et al, 1999]. Thus, the rational design of nanotherapeutics that simulate this surgical procedure may prove to be an effective strategy to developing new tumor-targeted therapies.…”
Section: Isolated Limb Perfusion Procedure: a Surgical Methods Of Tumomentioning
confidence: 99%
“…In effect, by localizing the delivery of TNF to solid tumors, Lienard and Lejuene harnessed the biology of TNF to induce at least one of the possible mechanisms by which the cytokine induces an anti-tumor response. For example, TNF has been shown to cause apoptosis directly in various tumor cell types Helson et al, 1975], to activate and drive immune-based anti-tumor responses [Asami et al, 1989], and to induce vascular leak in tumor blood vessels [Nawroth and Stern, 1986;Brett et al, 1989], leading to a destruction of the interstitial fluid pressure (IFP) gradient in solid tumors [Kristensen et al, 1996;Nedrebo et al, 1999]. Thus, the rational design of nanotherapeutics that simulate this surgical procedure may prove to be an effective strategy to developing new tumor-targeted therapies.…”
Section: Isolated Limb Perfusion Procedure: a Surgical Methods Of Tumomentioning
confidence: 99%
“…Early reports revealed a dual effect: a small direct cytotoxic activity on, at least some, tumor cell lines mediated by the apoptotic pathway and an immune stimulatory activity [86][87][88]; and a vast selective disruption of the tumor-associated vessels, inducing hemorrhagic necrosis [89,90].…”
Section: Mechanism Of Actionmentioning
confidence: 99%
“…As indicated in the literature, tumor regression is entirely dependent on T lymphocytes [ 4 , 22 , 50 ]. A suggested mechanism of this process is that TNF activates Th lymphocytes which in turn activate cytotoxic T lymphocytes (CTL) to destroy tumor cells [ 3 ]. Furthermore, some recent experiments on knockout mice have indicated TNF together with perforin and interferon γ as a critical triad of effector molecules in anti-tumor activity of CTL [ 57 ].…”
Section: Discussionmentioning
confidence: 99%